Product of the month

Olympus Color Cameras – Confidence in Your Images

Let your images tell the story with Olympus’ high-quality digital color cameras for microscopy in hospitals. With crisp, noise-free images and 4K UHD live viewing, the Olympus UC90 and SC180…

Cause and effect

Diabetes and heart failure: discovering the connection

Men with diabetes are 2.4 times more likely than non-diabetics to suffer heart failure and women are five times more likely. But why? A new Loyola University Chicago Stritch School of Medicine study…

Innovation award

Multi-organ "lab-on-a-chip" to reduce animal testing

To simulate the blood circulation and the organs of animals or humans, engineers from Fraunhofer in Dresden have developed a so-called "multi-organ chip". This microsystem from the…

Radiation protection

Using skin creams during radiation therapy: Is it safe?

Nearly two-thirds of all cancer patients in the United States will undergo radiation therapy as part of their treatment, and as many as 90 percent of those patients will experience radiation dermatitis – a rash or burn on the skin. Topical treatments commonly such as silver sulfadiazine cream contain heavy metals. Therefore, patients have historically been advised to avoid using these treatments in the hours before radiation therapy to avoid increasing the amount of radiation absorbed by the skin. However, a new study challenges this advice.

Pilot project

Could AI 'Audrey' be the future first response assistant?

Imagine a first responder answering the call to a natural disaster, a house fire, or an active shooter incident where there may be multiple injuries and unknown casualties. The information the…

Tuberculosis

So did drug resistant TB evolve and spread globally

The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and…

Latest headlines

Petition to improve and expand access to radiotherapy in the UK

A coalition of stakeholders including leaders from patient groups, academia, government and the private sector have released a report that provides recommendations to the NHS that would improve and expand access to advanced radiotherapy services in the UK amidst calls for increased funding by the all party parliamentary group for radiotherapy. The report builds upon a public petition led by the charity Action Radiotherapy. The petition asks to increase the NHS Cancer budget dedicated to radiotherapy from 5% to 6.5%, and a one-time £250 million investment to modernise existing machines and build satellite radiotherapy centres to ensure accessible service nationwide. Currently, the NHS spends only 5 percent of its budget on radiotherapy services although around 50 percent of cancer patients will need radiotherapy as a part of their treatment. More information on the petition can be found on https://www.actionradiotherapy.org/


DNAe wins OBN Award for Best Diagnostic Medtech Company

DNAe, the inventor of semiconductor-based genomic analysis technologies, and the developer of a new game-changing test for bloodstream infections (BSI) that can lead to sepsis, was named ‘Best Diagnostic Medtech Company’ at the 2018 OBN Awards. DNAe was recognized for its pioneering semiconductor DNA analysis and sample preparation1 technologies that underlie its breakthrough direct-from-blood, cartridge-based diagnostic in development, LiDia® BSI, as well as the developmental progress and disruptive potential of the LiDia® BSI method.


EU devises six-year Action Plan on childhood obesity

Childhood obesity remains a big public health issue in the European Union. In the European region it is estimated that 1 in 3 11 year olds is overweight or obese. 7% of national health budget across Europe is spent on diseases linked to obesity. To address this alarming issue, the EU envisaged a six year Action Plan on Childhood Obesity (2014-2020). The plan aims at demonstrating shared commitment among EU Member States, setting priority areas for actions and collectively keeping track of the progress. An international symposium on October 30, in Brussels offers an opportunity for all relevant stakeholders to engage with the EU Action Plan. Detailed information on the Action Plan and symposium can be found at Public Policy Exchange.


Siemens Healthineers reports strong comparable revenue growth

After its admission into TecDAX, Siemens Healthineers AG posted solid growth in revenue for the third quarter: Supported by the robust increase in the Imaging segment, revenue rose by five percent on a comparable basis over the third quarter last year; in absolute figures revenue was stable at EUR 3.3 billion. Adversely affected by significantly negative currency effects, the adjusted profit margin was 16.0 percent. Adjusted profit amounted to EUR 528 million, with adjusted net income reaching EUR 334 million. Earnings per share are at EUR 0.29. Atellica Solution deliveries are being accelerated and remain on schedule with more than 560 systems delivered up to the end of the third quarter. More details on the Q3 report on the Siemens Healthineers website.

Radiation therapy QA

IBA steps forward in online treatment monitoring

IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announces that it has…

ANESTHESIOLOGY 2018

Virtual reality reduces children’s anxiety and pain

Innovative virtual reality (VR) technologies hold promise in reducing children’s anxiety and pain before and after medical procedures and surgery, suggest two studies that were presented at the…

Products from Radbook

Ultrasound

Mindray Medical - DC-70 with X-Insight

Shenzhen Mindray Bio-Medical Electronics Co., Ltd

Bi-Plane

Canon - Infinix-i Dual Plane

Canon Europa NV

DR Retrofit

STEPHANIX - Nomad DReam

STEPHANIX

Film-screen mammography

Canon - Harmonia

Canon Europa NV

Displays - Mammo

Barco - Barco Coronis Uniti

Barco N.V.

Products from Labbook

Mass spectrometry

Shimadzu – MALDI-8020

Shimadzu Europa GmbH

Microscopy

Olympus - UC90 4K Microscopy

Olympus Europa SE & Co. KG

Clinical Chemistry

Beckman Coulter - AU480 Chemistry Analyzer

Beckman Coulter, Inc.

Amplification/Detection

Agena Bioscience - MassARRAY Colon Panel

Agena Bioscience GmbH

Research use only (RUO)

Eppendorf - BioSpectrometer fluroescence

Eppendorf AG

Clinical chemistry

Beckman Coulter - AU5800 Series

Beckman Coulter, Inc.

Mysterious blackout

What happens when we lose consciousness during anaesthesia?

The first successful surgery under anaesthesia occurred in the 1840s. Since then—more than 170 years later—people have been developing theories about what might be going on in the brain while a…

Research

Path to deadly sepsis varies by bacterial infection

Sepsis remains a common and deadly condition that occurs when the body reacts to an infection in the bloodstream. Scientists know little about the early stages of the condition; however, physicians…

Fairs & congresses

show more

Diabetes

Measuring glucose levels without drawing blood

Researchers recently evaluated the accuracy of a technology to monitor blood glucose levels without needles or a finger prick. Early results show that the noninvasive technology measures blood…

Bordetella

Launch of Hologic's whooping cough detection assay in Europe

Hologic, Inc. announced that its Panther Fusion Bordetella assay has received CE mark in Europe. This assay, the latest in a growing menu of Panther Fusion and Aptima assays, brings full automation,…

Experts warn

Brexit will Harm cancer research and health of citizens

Cancer experts warn that Brexit will seriously harm UK cancer research and could trigger a manpower crisis that will negatively affect the health of our citizens.

With less blood splatter

How to make a lab-on-a-chip clear and biocompatible

Lab-on-a-chip devices harness electrical signals to measure glucose, discern blood type and detect viruses or cancer. But biological samples need hafnium oxide for protection from electric fields.

Solving a medical mystery

Cause of rare type of dwarfism discovered

Scientists have uncovered the cause of Saul-Wilson syndrome: A single, spontaneous gene change alters protein packaging in the cell’s Golgi complex, causing the disease.